Read our policy on accessibility for our siteRead more

Duchenne UK launches the Duchenne Muscular Dystrophy Clinical Research Hub

Introducing the Hub and newly appointed Hub Manager: Emma Heslop.Read more

Clinical Trial Capacity

We’ve invested more than £500,000 to fund vital clinical trial posts at leading centres of excellence in the UKRead more

Duchenne UK and DMD Pathfinders launch campaign for treatments for Adults with DMD

The joint campaign will ensure that treatments and therapies developed are relevant and available to adults living with DMD.Read more

President & Patrons

HRH The Duchess of CornwallRead more

Meet The Team

Our Management team and Board of TrusteesRead more

Patient Advisory Board

Patient and parent involvement is at the heart of Duchenne UKRead more

Scientific Advisory Board

Our Scientific Advisory Board includes some of the world's leading experts in Duchenne muscular dystrophy.Read more

xmas resources

Read more

water bottle

Read more

january page

Read more


Read more

Patient representation

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Read more

Vamorolone (VBP15) – Clinical trial recruitment has begun

ReveraGen are recruiting for the clinical trial for Vamorolone which could offer a potential alternative to steroidsRead more

SOLID Gene Therapy

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus condimentum leo sed faucibus laoreet. Mauris ullamcorper dolor dictum sapien blandit, et condimentum dolor sagittis.Read more

Our Strategy To End Duchenne

Learn more about the work we are doingRead more